J
John Mills
Researcher at Mayo Clinic
Publications - 400
Citations - 24996
John Mills is an academic researcher from Mayo Clinic. The author has contributed to research in topics: Virus & Antibody. The author has an hindex of 74, co-authored 369 publications receiving 23101 citations. Previous affiliations of John Mills include Alfred Hospital & Ulster University.
Papers
More filters
Journal ArticleDOI
Genomic Structure of an Attenuated Quasi Species of HIV-1 from a Blood Transfusion Donor and Recipients
Nicholas J. Deacon,A. Tsykin,Ajantha Solomon,K. Smith,Mandy J. Ludford-Menting,David J. Hooker,Dale A. McPhee,Alison L. Greenway,Anne Ellett,Catherine Chatfield,Victoria A. Lawson,Suzanne M. Crowe,Anne L. Maerz,Secondo Sonza,Jenny Learmont,John S. Sullivan,Anthony L. Cunningham,Dominic E. Dwyer,David Dowton,John Mills +19 more
TL;DR: Data show that survival after HIV infection can be determined by the HIV genome and support the importance of nef or the U3 region of the LTR in determining the pathogenicity of HIV-1.
Journal ArticleDOI
Designing, implementing and updating performance measurement systems
TL;DR: It is concluded that specific processes are required to continuously align the performance measurement system with strategy and when these processes are combined with a well defined model of strategic success, the measurement system can enhance the strategic management process by challenging the assumptions and the strategy itself.
Journal ArticleDOI
Performance measurement system design: developing and testing a process‐based approach
TL;DR: Following a wide ranging review of the performance measurement literature, a framework identifying the desirable characteristics of a performance measurement system design process is developed and provided guidelines which were subsequently used to inform the development of a process‐based approach to performance measurementSystem design.
Journal ArticleDOI
EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis.
Max Yates,Max Yates,Richard A. Watts,Ingeborg M. Bajema,Maria C. Cid,Bruno Crestani,Thomas H. Hauser,Bernhard Hellmich,Julia U Holle,Martin Laudien,Mark A. Little,Raashid Luqmani,Alfred Mahr,Peter A. Merkel,John Mills,Janice Mooney,Mårten Segelmark,Vladimir Tesar,Kerstin Westman,Augusto Vaglio,Nilüfer Yalçındağ,David Jayne,Chetan Mukhtyar +22 more
TL;DR: The 2009 European League Against Rheumatism recommendations for the management of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) have been updated and 15 recommendations were developed, covering general aspects, such as attaining remission.
Journal ArticleDOI
Adverse Reactions to Trimethoprim-Sulfamethoxazole in Patients with the Acquired Immunodeficiency Syndrome
TL;DR: In patients with the acquired immunodeficiency syndrome, trimethoprim-sulfamethoxazole has a higher incidence of adverse reactions than pentamidine and appears earlier than toxicity associated withpentamidine.